Healthcare / Medical Instruments & SuppliesUpdated 2026-05-10 22:07 UTC

MMED stock hub

MiniMed Group, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

MMEDis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

3.2B

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

MMED

In the news

Latest news · MMED

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E37.9

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROEn/a

P25 -105.6P50 -46.5P75 -3.1

ROICn/a

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All MMED market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

173

Groups with data

Currency

USD

Showing 173 of 173 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0002062583
Company name	MiniMed Group, Inc.
Country	United States
Country code	US
Cusip	60365F109
Employees	8,000
Employees Change	0%
Employees Change Percent	0
Enterprise value	$3.3B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Medical Instruments & Supplies
IPO Date	2026-03-06
Isin	US60365F1093
Last refreshed	2026-05-10
Market cap	$3.2B
Market cap category	Mid-Cap
Price	$11.57
Price currency	USD
Rev Per Employee	373,625x
Sector	Healthcare
Sic	3841
Symbol	MMED
Website	https://www.minimed.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-9.85%
EV Sales Forward	0.97x
EV/EBIT	46.48x
EV/EBITDA	14.6x
EV/Sales	1.1x
FCF yield	-5.17%
Forward P/E	37.95x
P/B ratio	0.94x
P/S ratio	1.09x
PEG ratio	1.6x
PS Forward	0.96x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	2.38%
EBITDA Margin	7.56%
Gross margin	56.74%
Gross Profit	$1.7B
Gross Profit Growth	17.94%
Gross Profit Growth Q	1.24%
Net Income	$-320M
Net Income Growth Years	0%
Pretax Margin	-8.13%
Profit Margin	-10.71%
Profit Per Employee	$-40,000
ROCE	1.95

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS Growth Years	0
OCF Growth	36.59%
OCF Growth Q	300%
Revenue Growth	21.06x
Revenue Growth Q	21.17x
Revenue Growth Years	2x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$4.3B
Cash	$10M
Current Assets	$1.1B
Current Liabilities	$696M
Debt	$61M
Debt EBITDA	$0.26
Debt Equity	$0.02
Equity	$3.5B
Liabilities	$881M
Long Term Assets	$3.2B
Long Term Liabilities	$185M
Net Cash	$-51M
Net Cash By Market Cap	$-1.57
Net Debt EBITDA	$0.23
Net Debt Equity	$0.01
Tangible Book Value	$1.1B
Tangible Book Value Per Share	$3.89

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.59
Net Working Capital	$413M
Quick ratio	0.95
Working Capital	$412M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
All Time High	20.48
All Time High Change	-43.51%
All Time High Date	2026-03-06
All Time Low	11.25
All Time Low Change	2.84%
All Time Low Date	2026-05-08
ATR	0.84
Beta1y	1.38
High	12.08
High52	20.48
High52 Date	2026-03-06
High52ch	-43.51%
Low	11.25
Low52	11.25
Low52 Date	2026-05-08
Low52ch	2.84%
RSI	29.35
RSI Monthly	0
RSI Weekly	0
Sharpe ratio	-4.7x
Sortino ratio	-5.17
Tr1m	-12.35%
Tr1w	-4.46%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	10
Analyst Count Top	1
Analyst Price Target Top	$23
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.13
Earnings Revenue Estimate	828,057,312x
Operating Income	$71M
Operating margin	2.38
Price target	$22.56
Price Target Change	$94.99
Price Target Change Top	$98.79

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	28,000,003%
Float Percent	9.97%
Shares Insiders	0%
Shares Institutions	0.24%
Shares Out	280,819,988
Short Float	10.2%
Short Ratio	3.2
Short Shares	1.02

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-215M
Average Volume	743,411.85x
Bv Per Share	12.33
CAPEX	$-224M
Ch1m	-12.35
Ch1w	-4.46
Change	-1.36%
Change From Open	-1.87
Close	11.73
Days Gap	0.51
Depreciation Amortization	155,000,000
Dollar Volume	6,229,149.2
Earnings Date	2026-06-03
Earnings Time	bmo
EBIT	$71M
EBITDA	$226M
EPS	$-1.14
F Score	2
FCF	$-168M
FCF EV Yield	-5.09x
FCF Per Share	$-0.6
Financing CF	179,000,000
Fiscal Year End	April
Founded	1,983
Goodwill	2,256,000,000
Income Tax	$56M
Investing CF	-234,000,000
Ipr	-42.15
Iprfo	-39.27
Is Primary Listing	1
Is Spac	No
Last Report Date	2026-01-23
Last Split Type	Never
Ma20	13.06
Ma20ch	-11.44%
Next Earnings Date	2026-06-03
Open	11.79
Optionable	Yes
P OCF Ratio	58.02
Position In Range	38.55
Post Close	11.57
Postmarket Change Percent	1.99
Postmarket Price	$11.8
Ppne	761,000,000
Price Date	2026-05-08
Price EBITDA	$14.38
Ptbv Ratio	2.97
Relative Volume	0.72x
Revenue	2,989,000,000x
SBC By Revenue	1.57x
Share Based Comp	47,000,000
Tax By Revenue	1.87x
Us State	California
Volume	538,388

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does MMED pay a dividend?

Capital-return profile for this ticker.

Ownership

Who owns MMED?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.2%

Float: +10.0% of shares outstanding

Insider ownership

+0.0%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

MMED momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

29.3

Below 30: short-term oversold

Price vs 200-day MA

n/a

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

-4.70

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About MMED

Hub-level FAQ points readers to the deeper analysis pages.

What is the current MMED stock rating?

MiniMed Group, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full MMED analysis?

The full report lives at /stocks/MMED/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for MMED?

The latest report frames MMED around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the MMED page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.